Derek J. Royer

511 total citations
21 papers, 390 citations indexed

About

Derek J. Royer is a scholar working on Immunology, Epidemiology and Ophthalmology. According to data from OpenAlex, Derek J. Royer has authored 21 papers receiving a total of 390 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 11 papers in Epidemiology and 4 papers in Ophthalmology. Recurrent topics in Derek J. Royer's work include Herpesvirus Infections and Treatments (10 papers), interferon and immune responses (6 papers) and Immunotherapy and Immune Responses (4 papers). Derek J. Royer is often cited by papers focused on Herpesvirus Infections and Treatments (10 papers), interferon and immune responses (6 papers) and Immunotherapy and Immune Responses (4 papers). Derek J. Royer collaborates with scholars based in United States, United Kingdom and Netherlands. Derek J. Royer's co-authors include Daniel J.J. Carr, Christopher D. Conrady, Min Zheng, Deirdra R. Terrell, James N. George, Nico van Rooijen, Anthony M. Alleman, Douglas A. Drevets, Grzegorz B. Gmyrek and William P. Halford and has published in prestigious journals such as The Journal of Immunology, Journal of Virology and Scientific Reports.

In The Last Decade

Derek J. Royer

21 papers receiving 379 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Derek J. Royer United States 12 203 193 76 62 61 21 390
Maanasa Indaram United States 11 89 0.4× 117 0.6× 63 0.8× 160 2.6× 125 2.0× 24 420
Irene Keitelman Argentina 14 196 1.0× 55 0.3× 193 2.5× 61 1.0× 70 1.1× 21 493
John C. Gomez United States 10 230 1.1× 78 0.4× 78 1.0× 43 0.7× 25 0.4× 18 417
Kumarkrishna Raychaudhuri United States 6 173 0.9× 42 0.2× 106 1.4× 119 1.9× 27 0.4× 11 405
Liam M. Ashander Australia 15 112 0.6× 159 0.8× 83 1.1× 179 2.9× 27 0.4× 31 554
Margot L. Goodkin United States 10 75 0.4× 122 0.6× 30 0.4× 138 2.2× 65 1.1× 21 322
Sarah J. Kopp United States 13 108 0.5× 342 1.8× 49 0.6× 45 0.7× 14 0.2× 21 506
James C. McAlister United Kingdom 10 89 0.4× 100 0.5× 127 1.7× 225 3.6× 346 5.7× 16 559
WY Almawi Tunisia 10 225 1.1× 62 0.3× 34 0.4× 7 0.1× 14 0.2× 12 473

Countries citing papers authored by Derek J. Royer

Since Specialization
Citations

This map shows the geographic impact of Derek J. Royer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Derek J. Royer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Derek J. Royer more than expected).

Fields of papers citing papers by Derek J. Royer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Derek J. Royer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Derek J. Royer. The network helps show where Derek J. Royer may publish in the future.

Co-authorship network of co-authors of Derek J. Royer

This figure shows the co-authorship network connecting the top 25 collaborators of Derek J. Royer. A scholar is included among the top collaborators of Derek J. Royer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Derek J. Royer. Derek J. Royer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Whitehead, Gregory S., Seddon Y. Thomas, Keiko Nakano, et al.. (2022). A neutrophil/TGF-β axis limits the pathogenicity of allergen-specific CD4+ T cells. JCI Insight. 7(4). 7 indexed citations
2.
Filiberti, Adrian, et al.. (2021). An intact complement system dampens cornea inflammation during acute primary HSV-1 infection. Scientific Reports. 11(1). 10247–10247. 10 indexed citations
3.
Royer, Derek J. & Donald N. Cook. (2021). Regulation of Immune Responses by Nonhematopoietic Cells in Asthma. The Journal of Immunology. 206(2). 292–301. 5 indexed citations
5.
Carr, Daniel J.J., et al.. (2019). Virus-specific T cell receptor transgenic mice vaccinated with HSV-1 0ΔNLS limit HSV--induced corneal neovascularization in the absence of antibody. Investigative Ophthalmology & Visual Science. 60(9). 6416–6416. 1 indexed citations
7.
Royer, Derek J., Liwen Lin, Grzegorz B. Gmyrek, et al.. (2019). Complement and CD4+ T cells drive context-specific corneal sensory neuropathy. eLife. 8. 29 indexed citations
8.
Royer, Derek J., Michael H. Elliott, Yun Le, & Daniel J.J. Carr. (2018). Corneal Epithelial Cells Exhibit Myeloid Characteristics and Present Antigen via MHC Class II. Investigative Ophthalmology & Visual Science. 59(3). 1512–1512. 16 indexed citations
10.
Royer, Derek J., et al.. (2017). The Neonatal Fc Receptor and Complement Fixation Facilitate Prophylactic Vaccine-Mediated Humoral Protection against Viral Infection in the Ocular Mucosa. The Journal of Immunology. 199(5). 1898–1911. 15 indexed citations
11.
Royer, Derek J., Christopher D. Conrady, & Daniel J.J. Carr. (2016). Herpesvirus-Associated Lymphadenitis Distorts Fibroblastic Reticular Cell Microarchitecture and Attenuates CD8 T Cell Responses to Neurotropic Infection in Mice Lacking the STING-IFNα/β Defense Pathways. The Journal of Immunology. 197(6). 2338–2352. 11 indexed citations
12.
Royer, Derek J., et al.. (2016). A Highly Efficacious Herpes Simplex Virus 1 Vaccine Blocks Viral Pathogenesis and Prevents Corneal Immunopathology via Humoral Immunity. Journal of Virology. 90(11). 5514–5529. 25 indexed citations
13.
Royer, Derek J. & Daniel J.J. Carr. (2015). A STING-dependent innate-sensing pathway mediates resistance to corneal HSV-1 infection via upregulation of the antiviral effector tetherin. Mucosal Immunology. 9(4). 1065–1075. 41 indexed citations
14.
Royer, Derek J., Alex W. Cohen, & Daniel J.J. Carr. (2015). The current state of vaccine development for ocular HSV-1 infection. Expert Review of Ophthalmology. 10(2). 113–126. 17 indexed citations
15.
Royer, Derek J., Min Zheng, Christopher D. Conrady, & Daniel J.J. Carr. (2015). Granulocytes in Ocular HSV-1 Infection: Opposing Roles of Mast Cells and Neutrophils. Investigative Ophthalmology & Visual Science. 56(6). 3763–3763. 47 indexed citations
16.
McMurtrey, Curtis, Dave Lowe, Rico Buchli, et al.. (2013). Profiling antibodies to class II HLA in transplant patient sera. Human Immunology. 75(3). 261–270. 10 indexed citations
17.
Conrady, Christopher D., Min Zheng, Nico van Rooijen, et al.. (2013). Microglia and a Functional Type I IFN Pathway Are Required To Counter HSV-1–Driven Brain Lateral Ventricle Enlargement and Encephalitis. The Journal of Immunology. 190(6). 2807–2817. 71 indexed citations
18.
Royer, Derek J., James N. George, & Deirdra R. Terrell. (2010). Thrombocytopenia as an adverse effect of complementary and alternative medicines, herbal remedies, nutritional supplements, foods, and beverages*. European Journal Of Haematology. 84(5). 421–429. 32 indexed citations
19.
Royer, Derek J., James N. George, & Deirdra R. Terrell. (2010). THROMBOCYTOPENIA AS AN ADVERSE EFFECT OF COMPLEMENTARY AND ALTERNATIVE MEDICINES, HERBAL REMEDIES, NUTRITIONAL SUPPLEMENTS, FOODS, AND BEVERAGES. European Journal Of Haematology. 2 indexed citations
20.
Andreu, G., Emilie M. Hardy, M. Massé, et al.. (1996). Why Choose Apheresis Platelet Concentrates?. Transfusion Medicine and Hemotherapy. 23(Suppl. 1). 24–29. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026